Asahi tie-up, India growth, Africa expansion and new categories such as dairy, energy drinks and snacks are expected to ...

MODIIN, Israel and NEW YORK, Feb. 16, 2023 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), a biotechnology company developing targeted medicines for immune-inflammatory diseases, announced today ...

VBL is now continuing to enroll patients, working toward its enrollment target of 400 subjects (PDPics/Pixabay) () The independent data safety monitoring committee has cleared VBL Therapeutics to ...

Merger Expected to Close and Begin Trading as Combined Company Under the NTBL Ticker on Nasdaq Next Week, Subject to Effectiveness of Approved Israeli Corporate Actions MODI’IN, Israel and NEW YORK, ...

Shares in VBL Therapeutics have lost around 78% of their value in pre-market trading after the company reported a phase 3 trial of its lead gene therapy VB-111 for ovarian cancer failed a pivotal ...

Varun Beverages (VBL) shares have seen some volatility this week. SEBI-registered analyst Deepak Pal attributed this to three factors: profit booking after its recent upmove, technical support zone ...

CCO appointment positions VBL to advance and accelerate commercialization strategy for ofra-vec (VB-111) Enrollment in the OVAL Study, a 400 patient Phase 3 registration-enabling trial in ovarian ...

MODIIN, Israel and NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) announced today that it has closed on the previously announced sale of its manufacturing facility in ...